119 related articles for article (PubMed ID: 18053811)
1. Dissection of the functional interaction between p53 and the embryonic proto-oncoprotein PAX3.
Underwood TJ; Amin J; Lillycrop KA; Blaydes JP
FEBS Lett; 2007 Dec; 581(30):5831-5. PubMed ID: 18053811
[TBL] [Abstract][Full Text] [Related]
2. Pax3 stimulates p53 ubiquitination and degradation independent of transcription.
Wang XD; Morgan SC; Loeken MR
PLoS One; 2011; 6(12):e29379. PubMed ID: 22216266
[TBL] [Abstract][Full Text] [Related]
3. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
Taylor AC; Schuster K; McKenzie PP; Harris LC
Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
[TBL] [Abstract][Full Text] [Related]
4. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Phelps M; Phillips A; Darley M; Blaydes JP
J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837
[TBL] [Abstract][Full Text] [Related]
5. Defining the molecular basis of Arf and Hdm2 interactions.
Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
[TBL] [Abstract][Full Text] [Related]
6. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
7. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
9. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH
Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
11. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.
Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F
Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988
[TBL] [Abstract][Full Text] [Related]
12. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein.
Dobbelstein M; Wienzek S; König C; Roth J
Oncogene; 1999 Mar; 18(12):2101-6. PubMed ID: 10321734
[TBL] [Abstract][Full Text] [Related]
14. Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest.
Morgan SC; Lee HY; Relaix F; Sandell LL; Levorse JM; Loeken MR
Mech Dev; 2008; 125(9-10):757-67. PubMed ID: 18672055
[TBL] [Abstract][Full Text] [Related]
15. Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.
Popowicz GM; Czarna A; Holak TA
Cell Cycle; 2008 Aug; 7(15):2441-3. PubMed ID: 18677113
[TBL] [Abstract][Full Text] [Related]
16. Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2.
de Graaf P; Little NA; Ramos YF; Meulmeester E; Letteboer SJ; Jochemsen AG
J Biol Chem; 2003 Oct; 278(40):38315-24. PubMed ID: 12874296
[TBL] [Abstract][Full Text] [Related]
17. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300.
Dornan D; Hupp TR
EMBO Rep; 2001 Feb; 2(2):139-44. PubMed ID: 11258706
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length.
Lai Z; Auger KR; Manubay CM; Copeland RA
Arch Biochem Biophys; 2000 Sep; 381(2):278-84. PubMed ID: 11032416
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the inhibition of p53 by Mdmx.
Popowicz GM; Czarna A; Rothweiler U; Szwagierczak A; Krajewski M; Weber L; Holak TA
Cell Cycle; 2007 Oct; 6(19):2386-92. PubMed ID: 17938582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
